Real-time enrollment status for this primary immunodeficiency (pid) clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 3:21 PM UTC
| NCT Number | NCT01962415 |
| Recruiting Status | Recruiting |
| Condition | Primary Immunodeficiency (PID) |
| Phase | PHASE2 |
| Target Enrollment | 100 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Paul Szabolcs |
| Last Updated on CT.gov | December 15, 2025 (Dec 15, 2025) |
As of July 18, 2026: Clinical trial NCT01962415 is currently recruiting participants. This phase2 study for primary immunodeficiency (pid) is actively seeking new participants at 1 location across the United States. The study is sponsored by Paul Szabolcs. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT01962415 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT01962415 was last updated Dec 15, 2025 (December 15, 2025). HelloStudys verifies this status automatically.